Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study

NCT02678884 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: 18-F FDG

Sponsor

University Health Network, Toronto